Dr. Kram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-1000Fax+1 919-966-7629
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Hematology/Oncology, 2013 - 2016
- University of ConnecticutResidency, Pediatrics, 2010 - 2013
- Tel Aviv University SacklerClass of 2010
Certifications & Licensure
- OR State Medical License 2013 - Present
- NC State Medical License 2016 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
- Promoting Altruism to Enhance Vaccine Acceptance Start of enrollment: 2020 Oct 19
Publications & Presentations
PubMed
- 18 citationsTargetable BRAF and RAF1 Alterations in Advanced Pediatric CancersAndrew Rankin, Adrienne Johnson, Alison Roos, Geoffrey Kannan, Jeffrey Knipstein
The Oncologist. 2021-01-01 - Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.Andge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, Yuri Trunin, Alexander Savateev
The Oncologist. 2020-02-01 - 152 citationsInfant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomesMatthew Clarke, Alan Mackay, Britta Ismer, Jessica C Pickles, Ruth G. Tatevossian
Cancer Discovery. 2020-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: